Profil
Mr. John R.
Costantino is a Managing Director at Walden Partners Ltd., a Chairman at Vivaldi Biosciences, Inc., a Chairman-Supervisory Board at Vivaldi Biosciences AG, a Managing General Partner at NGN Capital LLC and a Principal at New World Health LLC.
He is on the Board of Directors at ACT Biotech, Inc., Muscular Dystrophy Association, Inc. and Visum Pharma, Inc.
Mr. Costantino was previously employed as a Principal by Promosome LLC and a Partner by Walden Capital Management Corp.
He also served on the board at Artes Medical, Inc., Ameriscape, Inc., Artisan Pharma, Inc. and Medrium, Inc.
He received his undergraduate degree from Fordham University and a graduate degree from Fordham University School of Law.
Postes actifs de John Costantino
| Sociétés | Poste | Début |
|---|---|---|
NGN Capital LLC
NGN Capital LLC Investment ManagersFinance NGN Capital invests in companies located in the United States and Europe. The firm targets companies operating in the fields of healthcare and biotechnology. It participates in early and later stage capital requirements. | Private Equity Investor | - |
Walden Partners Ltd. | Corporate Officer/Principal | 01/01/1992 |
ACT Biotech, Inc.
ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs | Directeur/Membre du Conseil | - |
Vivaldi Biosciences, Inc.
Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Develops and markets vaccines | Président | - |
Vivaldi Biosciences AG
Vivaldi Biosciences AG BiotechnologyHealth Technology Develops genetically engineered intranasal vaccines | Président | - |
New World Health LLC
New World Health LLC Investment ManagersFinance New World Health invests in companies located in the United States. The firm targets companies operating in the field of the health sector. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Muscular Dystrophy Association, Inc.
Muscular Dystrophy Association, Inc. Hospital/Nursing ManagementHealth Services Conducts research and provides medical services | Directeur/Membre du Conseil | - |
Visum Pharma, Inc.
Visum Pharma, Inc. Pharmaceuticals: MajorHealth Technology Provides therapeutics for neurodegenerative diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de John Costantino
| Sociétés | Poste | Fin |
|---|---|---|
Artes Medical, Inc.
Artes Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures, commercializes of injectable aesthetic products for dermatology and plastic surgery markets | Directeur/Membre du Conseil | 02/07/2013 |
| ░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de John Costantino
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Medrium, Inc.
Medrium, Inc. Internet Software/ServicesTechnology Services Provides web-based billing solutions | Technology Services |
NGN Capital LLC
NGN Capital LLC Investment ManagersFinance NGN Capital invests in companies located in the United States and Europe. The firm targets companies operating in the fields of healthcare and biotechnology. It participates in early and later stage capital requirements. | Finance |
Ameriscape, Inc.
Ameriscape, Inc. Wholesale DistributorsDistribution Services Provides mulch and bark products | Distribution Services |
Vivaldi Biosciences, Inc.
Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Develops and markets vaccines | Retail Trade |
Promosome LLC
Promosome LLC BiotechnologyHealth Technology Provides technologies related to the translation component of protein synthesis | Health Technology |
Artes Medical, Inc.
Artes Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures, commercializes of injectable aesthetic products for dermatology and plastic surgery markets | Health Technology |
Fordham University
Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Walden Capital Management Corp.
Walden Capital Management Corp. Investment ManagersFinance Walden Capital Mgmt, an SBIC, invests in companies located in the United States. The firm target companies operating in the fields of information technology, medical/healthcare, manufacturing and other technology businesses. It provides financing for early, later stage and growth capital requirements with an investment size up to $4 million. The firm also takes minority position in the company and a board seat. | Finance |
Muscular Dystrophy Association, Inc.
Muscular Dystrophy Association, Inc. Hospital/Nursing ManagementHealth Services Conducts research and provides medical services | Health Services |
Walden Partners Ltd. | |
Artisan Pharma, Inc.
Artisan Pharma, Inc. Hospital/Nursing ManagementHealth Services Provides critical-care and hospital-based therapeutics to patients | Health Services |
ACT Biotech, Inc.
ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs | Health Technology |
Fordham University School of Law
Fordham University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivaldi Biosciences AG
Vivaldi Biosciences AG BiotechnologyHealth Technology Develops genetically engineered intranasal vaccines | Health Technology |
New World Health LLC
New World Health LLC Investment ManagersFinance New World Health invests in companies located in the United States. The firm targets companies operating in the field of the health sector. It provides financing for early stage capital requirements. | Finance |
Visum Pharma, Inc.
Visum Pharma, Inc. Pharmaceuticals: MajorHealth Technology Provides therapeutics for neurodegenerative diseases | Health Technology |
















